Capital Advisory Group Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-780
Closed -$56K 455
2022
Q1
$56K Buy
+780
New +$56.2K 0.03% 235
2021
Q4
Sell
-5,119
Closed -$649K 461
2021
Q3
$649K Buy
5,119
+257
+5% +$37.4K 0.24% 97
2021
Q2
$809K Buy
4,862
+258
+6% +$41.8K 0.29% 86
2021
Q1
$837K Buy
4,604
+439
+11% +$102K 0.33% 80
2020
Q4
$833K Buy
4,165
+2,834
+213% +$576K 0.35% 68
2020
Q3
$292K Buy
1,331
+114
+9% +$24.1K 0.15% 102
2020
Q2
$232K Buy
1,217
+982
+418% +$172K 0.13% 115
2020
Q1
$36K Buy
+235
New +$27.3K 0.04% 127

Other funds holding TDOC

Capital Advisory Group Advisory Services's TDOC Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 780 shares — an estimated $56K sold.

Capital Advisory Group Advisory Services first reported a position in TDOC in Q1 2020 and held it in 8 quarters. The position peaked at $837K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 780 Teladoc Health shares in Q2 2022, an estimated $56K.
  • Capital Advisory Group Advisory Services first reported a position in Teladoc Health in Q1 2020 and held it in 8 quarters.
  • Capital Advisory Group Advisory Services's Teladoc Health position peaked at $837K in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.